Mumbai, November 18, 2017: Advanced Enzyme Technologies Limited (Advanced Enzymes; NSE: ADVENZYMES; BSE: 540025), a leading specialty biotech company, with global leadership in the manufacturing of enzymes, today announced their unaudited financial results for second quarter ended September 2017.
Financial Highlights – Q2FY18 vs Q2FY17:
- Consolidated Q2FY18 Sales (net of excise duty) up 9% YoY to INR 986 mn against INR 904 mn in Q2FY17
- Consolidated EBITDA for Q2FY18 stands at INR 414 mn against INR 487 mn in Q2FY17, down 15%
- Consolidated EBITDA Margin for Q2FY18 stands at 42% as against 52% in Q2FY17
- Consolidated Q2FY18 Net Profit down 23% at INR 224 mn against INR 291 in Q2FY17
Financial Highlights – H1FY18 vs H1FY17:
- Consolidated H1FY18 Sales (net of excise duty) down 6% YoY to INR 1,742 mn against INR 1,847mn in H1FY17
- Consolidated EBITDA for H1FY18 stands at INR 712 mn against INR 997 mn in H1FY17, down 29%
- Consolidated EBITDA Margin for H1FY18 stands at 40% as against 52% in H1FY17
- Consolidated H1FY18 Net Profit down 32% at INR 387 mn against INR 569 in H1FY17
Corporate Comm India(CCI Newswire)
